- Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington's Disease via Recovered Hepatic Pathological Changes
- Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases
- Nebulization of low-dose aspirin ameliorates Huntington's pathology in N171-82Q transgenic mice
- Serum Neurofilament Light and Clinical Biomarkers for Disease Staging in Huntington's Disease
- Compromised retinoic acid receptor beta (RARb) accelerates the onset of motor, cellular and molecular abnormalities in mouse model of Huntington's disease.
- Depressed and Nowhere to go for help: Using Telepsychiatry and Intramuscular Ketamine to Treat a Suicidal Patient with Huntington's Disease in the General Hospital
- Language-Independent Acoustic Biomarkers for Quantifying Speech Impairment in Huntington's Disease
- Systemic Symptoms in Huntington's Disease: A Comprehensive Review
- Treatment of Depression in Huntington's Disease: A Systematic Review
- Elimination of virus-like particles reduces protein aggregation and extends replicative lifespan in <em>Saccharomyces cerevisiae</em>
- Activation of autophagy by Citri Reticulatae Semen extract ameliorates amyloid-beta-induced cell death and cognition deficits in Alzheimer's disease
- Emerging Evidence of Golgi Stress Signaling for Neuropathies
- An assessment of crucial structural contributors of HDAC6 inhibitors through fragment-based non-linear pattern recognition and molecular dynamics simulation approaches
- Assessment of Perivascular Space Morphometry Across the White Matter in Huntington's Disease Using MRI
- Theory of Mind in Huntington's Disease: A Systematic Review of 20 Years of Research
- Structural mechanisms for VMAT2 inhibition by tetrabenazine
- Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases
- Comprehensive analysis of the genetic variation in the LPA gene from short-read sequencing
- Activation of alpha-7 nicotinic acetylcholine receptor by tropisetron mitigates 3-nitropropionic acid-induced Huntington's disease in rats: Role of PI3K/Akt and JAK2/NF-kappaB signaling pathways
- Development and Characterization of a Novel Carbon-11 Labeled Positron Emission Tomography Radiotracer for Neuroimaging of Sirtuin 1 with Benzoxazine-Based Compounds
- Novel Heterocyclic Compounds for Treating Huntington's Disease
- Multi-omics Identify Serotonin Transporter as a Promising Therapeutic Target for Essential Tremor
- Temporal dynamics and maturation of resting-state activity in preterm infants
- Mutant huntingtin protein induces MLH1 degradation, DNA hyperexcision, and cGAS-STING-dependent apoptosis
- Cognitive dysfunction, social behavior disorder, cerebellar ataxia, and atypical brain FDG-PET presentation in spinocerebellar ataxia 17: a case report
- Identifying and verifying Huntington's disease subtypes: Clinical features, neuroimaging, and cytokine changes
- Patient-derived neuron model: capturing age-dependent adult-onset degenerative pathology in Huntington's disease
- Dietary polyphenols represent a phytotherapeutic alternative for gut dysbiosis associated neurodegeneration: A Systematic review
- Freesurfer Software Update Significantly Impacts Striatal Volumes in the Huntington's Disease Young Adult Study and Will Influence HD-ISS Staging
- Effects of an Angiotensin IV Analog on 3-Nitropropionic Acid-Induced Huntington's Disease-Like Symptoms in Rats
- Huntington's Disease Clinical Trials Update: February 2024
- Characterizing Heart Rate Variability Response to Maximal Exercise Testing in People with Huntington's Disease
- Defining Parkinson's Disease: Past and Future
- Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder in Huntington Disease Patient with Improvement in Neuropsychiatric and Movement Symptoms: A Case Report
- Dispensaries and Medical Marijuana Certifications and Indications: Unveiling the Geographic Connections in Pennsylvania, USA
- Age-dependent somatic expansion of the ATXN3 CAG repeat in the blood and buccal cell DNA of individuals with spinocerebellar ataxia type 3
- Large animal models for Huntington's disease research
- Is maintenance therapy warranted for recurrent mania in a woman with a positive family history of Huntington's disease?
- The polyglutamine domain is the primary driver of seeding in huntingtin aggregation
- Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases
- PRMT5 is required for full-length HTT expression by repressing multiple proximal intronic polyadenylation sites
- Aberrant homeodomain-DNA cooperative dimerization underlies distinct developmental defects in two dominant CRX retinopathy models
- Concern about Tominersen in Patients with Huntington's Disease. Reply
- Concern about Tominersen in Patients with Huntington's Disease
- Nucleation of Huntingtin Aggregation Proceeds via Conformational Conversion of Pre-Formed, Sparsely-Populated Tetramers
- Experiences of young people growing up in a family with Huntington's disease: A meta-ethnography of qualitative research
- Fractal Dimension Studies of the Brain Shape in Aging and Neurodegenerative Diseases
- Fractal Analysis in Neurodegenerative Diseases
- A practical guide for clinical approach to patients with Huntington's disease in Korea
- Optimizing Screening for Intrastriatal Interventions in Huntington's Disease Using Predictive Models
- Dual-task assessments for predicting future falls in neurologic conditions: A systematic review
- Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration
- Non-coding RNAs and neuroinflammation: implications for neurological disorders
- Alterations in Cerebrospinal Fluid Urea Occur in Late Manifest Huntington's Disease
- Glycine transporter-1 inhibition by NFPS promotes neuroprotection against striatal damage models
- Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissues
- TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration
- Assessing the Validity and Reliability of HD-DOT TD-fNIRS Resting-State Measurements in Rapid Succession Data Collection Settings
- Beyond homogeneity: Charting the landscape of heterogeneity in psychiatric electroencephalography
- Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats
- A Case of Chorea with Slow Saccades Caused by NKX2-1 Mutation
- Disentangling the neurobiological bases of temporal impulsivity in Huntington's disease
- Assessment of Fitbit Charge 4 for sleep stage and heart rate monitoring against polysomnography and during home monitoring in Huntington's disease
- Modification of Huntington's disease by short tandem repeats
- Repeating themes of plastic genes and therapeutic schemes targeting the 'tandem repeatome'
- Ribosome Profiling and Mass Spectrometry Reveal Widespread Mitochondrial Translation Defects in a Striatal Cell Model of Huntington Disease
- Understanding of referential dependencies in Huntington's disease
- Neuroimmune pathways involvement in neurodegeneration of R6/2 mouse model of Huntington's disease
- Cross Talks between CNS and CVS Diseases: An Alliance to Annihilate
- Involvement of Autophagic Machinery in Neuropathogenesis: Targeting and Relevant Methods of Detection
- Cardiac autonomic involvement in Huntington's disease
- Disrupted nuclear import of cell cycle proteins in Huntington's/PolyQ disease causes neurodevelopment defects in cellular and Drosophila model
- Somatic CAG repeat instability in intermediate alleles of the HTT gene and its potential association with a clinical phenotype
- ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice
- Mono- and Biallelic Inactivation of Huntingtin Gene in Patient-Specific Induced Pluripotent Stem Cells Reveal HTT Roles in Striatal Development and Neuronal Functions
- Imaging and Assay of the Dynamics of Cytotoxic Huntingtin (HTT) Protein Aggregates Regulated by lncRNAs
- Role of Amyloid Beta in Neurodegeneration and Therapeutic Strategies for Neuroprotection
- Drosophila melanogaster Neuromuscular Junction as a Model to Study Synaptopathies and Neuronal Autophagy
- The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
- Exploring bradyphrenia in Huntington's disease using the computerized test of information processing (CTiP)
- Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington's disease
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- The contribution of preclinical magnetic resonance imaging and spectroscopy to Huntington's disease
- Large-scale screening of clinical assessments to distinguish between states in the Integrated HD Progression Model (IHDPM)
- Childhood-onset Huntigntons disease. A rare presentation
- Huntington disease - Update on ongoing therapeutic developments and a look toward the future
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Anticoagulation-related complications and their outcomes in hemodialysis patients with acute kidney injury at selected hospitals in Ethiopia.
- Analysis and validation of potential ICD-related biomarkers in development of myopia using machine learning
- Plasticity of gene expression in the nervous system by exposure to environmental odorants that inhibit HDACs
- Electroconvulsive Therapy for Obsessive and Compulsive Symptoms in Preclinical Huntington Disease: A Case Report
- Identifying temporal patterns in the progression of neurodegenerative disease using unsupervised clustering
- Microglia in brain aging: An overview of recent basic science and clinical research developments
- An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid
- Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics
- Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases
- Deregulated Transcriptome as a Platform for Adrenal Huntington's Disease-Related Pathology
- Corrigendum to "Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease" [Neurobiology of Disease, 2024 Jan:190:106376]
- CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders
- Selective Vulnerability to Neurodegenerative Disease: Insights from Cell Type-Specific Translatome Studies
RSS Feed – Literature
HDinHD > RSS Feed – Literature